HOME
SEARCH
RSS FEED
SUBSCRIBE
Multiplex Assay for Detection of Dengue Virus
Case ID:
TAB-2603
Web Published:
12/6/2022
Description:
Dengue virus (DENV) is the cause of dengue illness (dengue fever, dengue hemorrhagic fever, and dengue shock syndrome). CDC researchers have developed a RT-PCR multiplex assay that, prior to sero-conversion, selectively detects dengue virus in biological or other fluid media, such as whole blood, plasma, or serum. The primers and probes from this assay are sufficiently specific to amplify and detect all four DENV serotypes. This FDA-approved technology may provide an improved method for rapid and accurate serotyping of dengue virus in clinical and research settings.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Multiplex_Assay_for_Detection_of_Dengue_Virus
Category(s):
Licensing
Diagnostics
Infectious Disease
Rare/Neglected Diseases
Bookmark this page
Download as PDF
For Information, Contact:
Jeremiah Mitzelfelt
LPM
NIH Technology Transfer
301-443-8518
jeremiah.mitzelfelt@nih.gov
Inventors:
Edgardo Vergne
Gilberto Santiago
Jorge Munoz-Jordan
Keywords:
Broad
DA4BXX
DA4XXX
DAXXXX
DENGUE
Detection
DXXXXX
Serotypes
UB1XXX
virus
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum